UltraTech Cement Full Year 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St

UltraTech Cement (NSE:ULTRACEMCO) Full Year 2025 Results

Key Financial Results

  • Revenue: ₹759.6b (up 7.1% from FY 2024).
  • Net income: ₹60.4b (down 14% from FY 2024).
  • Profit margin: 8.0% (down from 9.9% in FY 2024). The decrease in margin was driven by higher expenses.
  • EPS: ₹205 (down from ₹243 in FY 2024).
We've discovered 1 warning sign about UltraTech Cement. View them for free.
NSEI:ULTRACEMCO Revenue and Expenses Breakdown May 4th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

UltraTech Cement Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 2.8%. Earnings per share (EPS) missed analyst estimates by 6.7%.

In the last 12 months, the only revenue segment was Cement and Cement Related Products contributing ₹759.6b. The largest operating expense was Sales & Marketing costs, amounting to ₹174.6b (46% of total expenses). Explore how ULTRACEMCO's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, while revenues in the Basic Materials industry in India are expected to remain flat.

Performance of the Indian Basic Materials industry.

The company's shares are down 4.8% from a week ago.

Risk Analysis

It is worth noting though that we have found 1 warning sign for UltraTech Cement that you need to take into consideration.

Valuation is complex, but we're here to simplify it.

Discover if UltraTech Cement might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.